AI/ML Innovations Inc. Announces Upcoming Webinar
AI/ML Innovations Inc. Announces Upcoming Webinar
VICTORIA, BC / ACCESSWIRE / July 9, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leading innovator in Artificial Intelligence and Machine Learning solutions, is pleased to announce an upcoming live webinar event. The webinar is scheduled for July 11th at 9:00 AM PT / 12:00 PM ET and will be broadcast online.
AI/ML创新公司（"AI/ML"或"公司"）（cse:aiml）（otcqb:aimlf）（fwb:42fb）是人工智能和机器学习解决方案领先的创新者，欣然宣布即将举行一次在线研讨会。研讨会定于7月11日上午9:00 Pt / 下午12:00 Et在线播出。
This event will feature Paul Duffy, Chief Executive Officer of AI/ML Innovations Inc., who will provide a comprehensive recap of the past 90 days, an overview of the upcoming 90 days, and outline key Q3 milestones.
本次活动将邀请AI/ML创新公司的首席执行官保罗·达菲提供过去90天的全面回顾，未来90天的概述以及Q3的关键里程碑。
We invite all shareholders and interested parties to join us for this informative session.
我们邀请所有股东和感兴趣的人参加此信息会议。
Register here for our live event: AI/ML Innovations Inc. Q2 Recap, Next 90, and Q3 Milestones
在此注册我们的现场活动：AI/ML创新公司Q2回顾，未来90天和Q3里程碑
For more information about AI/ML Innovations:
For detailed information please see AI/ML's website or the Company's filed documents at .
执行董事Tim Daniels:
有关详细信息，请参见AI/ML的网站或公司在...的文件。
For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com.
如需更多信息，请联系Blake Fallis，电话：（778）405-0882或电子邮件：info@aiml-innovations.com。
About AI/ML Innovations Inc.
AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (95.2% owned by AIML), Tech2Heal (up to 22% ownership rights, with 12.44% currently owned by AIML), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".
关于人工智能/机器学习创新公司。
更多关于AI/ML创新公司的信息
On behalf of the Board of Directors
Tim Daniels, Executive Chairman
谨代表董事会
AI/ML Innovations Inc.已重新调整其业务运营以利用人工智能（AI）和机器学习（ML）的蓬勃发展，初始投资重点放在利用AI、ML、云计算和数字平台推动变革性健康管理解决方案和精准支持交付的新兴数字健康和健康公司上。通过与健康仪表盘（AIML持有95.2%的所有权）、Tech2Heal（最高持股22%，目前AIML拥有12.44%的所有权）、AI Rx Inc.（AIML持有70%的所有权）和其他计划中的增值投资进行战略合作，该公司继续利用不断扩大的增长领域，造福于公司的所有利益相关者。AI/ML的股票在加拿大证券交易所上市，代码为“AIML”，在OTCQB Venture Market上市，代码为“AIMLF”，在Frankfurt Stock Exchange上市，代码为“42FB”。
THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES IN ANY JURISDICTION, NOR SHALL THERE BE ANY OFFER, SALE, OR SOLICITATION OF SECURITIES IN ANY STATE IN THE UNITED STATES IN WHICH SUCH OFFER, SALE, OR SOLICITATION WOULD BE UNLAWFUL.
本新闻稿不构成在任何司法管辖区出售或购买任何证券的要约，也不应该有任何在美国任何州出售或购买证券的要约、出售或征求。
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
CSE及其规则服务提供者（该术语在CSE的政策中定义）不对此公告的充分性或准确性承担责任。
SOURCE: AI/ML Innovations, Inc.
来源：AI/ML创新公司，Inc.